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Matrix metalloproteinases (MMPs) are a family of proteinases that degrade the basement membrane and have been
implicated in promoting tumor metastasis. MMP-2, one member of this family, was recently found to be a p53 target
and subject to p53 upregulation. In this study, we examined the correlation between the expression of MMP-2 and the
increased expression of p53 after g-irradiation. Three human p53-positive cell lines that express wild-type p53,
including U2-OS (osteosarcoma), RKO (colon carcinoma), MCF-7 (breast carcinoma), one mouse p53 positive cell line
and HepG2 (liver carcinoma), and two p53-negative human cell lines, SAOS-2 (osteosarcoma) and RKO-E6 (colon
carcinoma), were used in this study. The MMP-2 activity was analyzed by using gelatin zymography. The p53 level was
measured by western blot analysis. Our results show that wild-type p53 induced by ionizing radiation caused a
subsequent increase of MMP-2 activity in U2-OS and RKO cells but not in MCF-7, HepG2, SAOS-2, or RKO-E6 cells.
These results suggest that the g-radiation±induced expression of MMP-2 is dependent on the cell type and presence of
functional p53. Thus, ionizing radiation could activate MMP-2 activity in a subset of human cancer cells and may lead
to an increase in their metastatic potential. Mol. Carcinog. 27:252±258, 2000. ß 2000 Wiley-Liss, Inc.
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INTRODUCTION
The degradation of the basement membrane is
catalyzed by a family of matrix metalloproteinases
(MMPs) [1]. MMPs play an important role in
regulating various physiological processes, such as
embryonic development and wound healing, as
well as pathological processes such as cancer
metastasis and arthritis [2,3]. Studies have shown
that the basement membranes of the extracellular
matrix are composed mostly of a type IV collagen
[4]. The integrity of the basement membrane
surrounding a solid tumor is crucial in constraining
the invasion and metastasis of the tumor. Invading
cancer cells must break down the basement mem-
brane and in®ltrate the bloodstream and/or lym-
phatic system in order to invade distant organs.
These invading cancer cells penetrate the basement
membrane by secreting proteolytic enzymes that
catalyze the degradation of the collagen matrix in
the basement membrane [5]. One of the proteolytic
enzymes that degrade the basement membrane is
the 72-kDa type IV collagenase known as MMP-2 or
gelatinase A [5,6]. Increased expression of MMP-2 is
detected in human colonic adenocarcinoma [7],
whereas MMP-2 is knockout mice have reduced
angiogenesis and tumor progression capabilities [8];
these experiments support the notion that MMP-2
promotes tumor progression and metastasis.
p53 is a tumor suppressor gene as well as a
transcriptional factor that controls cell growth by
the induction of apoptosis and G1 arrest. This is
mainly achieved by p53-induced induction of bax
and p21 [9±11]. Intracellular p53 levels can be
altered through the exposure of the cells to various
insults such as chemical agents [12], ultraviolet
radiation [13], and ionizing radiation [14]. We have
recently shown that MMP-2 is a p53 target that is
subjected to p53 upregulation [15]. Indeed, induc-
tion of p53 by the DNA-damaging chemotherapeu-
tic agent etopside increases the level of MMP-2
mRNA expression [15]. This study implied that
ionizing radiation that activates p53 would increase
MMP-2 activity in a subset of human cell lines and
may lead to increases in their metastatic potential
[16]. To extend this study, we investigated the
correlation between p53 activation and MMP-2
induction in multiple cultured human and mouse
MOLECULAR CARCINOGENESIS 27:252±258 (2000)
ß 2000 WILEY-LISS, INC.
*Correspondence to: Department of Radiation Oncology, Division
of Radiation and Cancer Biology, University of Michigan Medical
School, Ann Arbor, MI 48109.
Received 22 July 1999; Revised 29 December 1999; Accepted 10
January 2000
Abbreviations: MMP, matrix metalloproteinase; SDS, sodium
dodecyl sulfate.
carcinoma cell lines harboring functional p53 or
inactive p53. We chose g-radiation as a p53
activator, since radiation is such a widely used
treatment modality in cancer therapy. We report
here that ionizing radiation induced MMP-2 expres-
sion in a p53- and cell line-dependent manner.
MATERIALS AND METHODS
Cell Culture and g-Irradiation
U2-OS and SAOS-2 cells were cultured in McCoy's
5A medium containing 10% fetal calf serum (FCS),
L-glutamine, and antibiotics. The RKO and RKO-E6
cells were obtained from Dr. Theodore Lawrence's
lab and were cultured in RPMI 1640 containing
10% FCS and penicillin/streptomycin (100 U/mL).
MCF-7 cells were cultured in RPMI 1640 containing
10% FCS and penicillin/streptomycin (100 U/mL).
HepG2 were cultured in Dulbeccos' modi®ed Eagle's
medium containing 10% FCS and penicillin/strep-
tomycin (100 U/mL). The cells were cultured in 60-
mm tissue culture plates in an incubator supplied
with 5% CO2 at 37
C. The cells were irradiated with
an absorbed dose of 5 Gy by using a 60Co teletherapy
unit with a dose rate of 1.49 Gy/min (Atomic Energy
of Canada, Missisauga, Ontario).
Collection of Condition Media and
Preparation of Cell Lysates
After the cells were g-irradiated, the cell culture
media were replaced with fresh serum-free media.
The conditioned media from both g-irradiated and
nonirradiated cells were collected at 0, 4, 8, 12, and
24 h postirradiation. In parallel, the cell lysates were
prepared by using Tris-glycine sample buffer [0.2 M
Tris±HCl, pH 6.8, 5% (v/v) glycerol, 0.1% bromo-
phenol blue, and 5% sodium dodecyl sulfate (SDS)].
Cells from each six-well plate were lysed in 200 mL of
the Tris±glycine sample buffer. The cell lysates were
subsequently sonicated by using a sonicator dis-
membranator (Fisher Scienti®c, Pittsburgh, PA),
aliquoted, and stored at ÿ20C.
Western Blot Analysis
The proteins in the cell lysates were resolved on a
10% SDS-polyacrylamide gel and electrophorized
for 50 min at 200 V. The proteins were then
transferred to nitrocellulose membranes (BioTrace
HP, Gelman Sciences, Ann Arbor, MI) at 4C (65 V,
3 h). The membranes were incubated with a
p53-Ab2 mouse monoclonal antibody (Calbiochem,
La Jolla, CA) at a 1:2000 dilution in TBST (0.1 M
Tris±HCl, pH 6.8, 137 mM NaCl, and 0.1% Tween
20) with 1% gelatin. The membranes were then
probed with an anti-mouse horseradish peroxidase±
conjugated secondary antibody and visualized by
using a supersignal chemiluminescent kit according
to the manufacture's procedure (Pierce, Rockford,
IL). Protein loading was standardized through a
western blot by using mouse anti±human b-actin
monoclonal antibodies (Sigma, St. Louis, MO) at a
1:10 000 dilution. Following the same procedure,
the expression levels of p21 and bax were probed
with a mouse anti-p21/WAF antibody (Santa Cruz
Biotech., Santa Cruz, CA) and a rabbit anti-bax anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA).
Gelatin Zymography
MMP-2 levels were measured by using gelatin
zymography. A 10% SDS-polyacrylamide gel was
cast in the presence of 0.1% gelatin. The condi-
tioned medium was mixed with an equal volume of
the 2 Tris±glycine sample buffer described above.
The samples were loaded and electrophorized at 125
V for 90 min. After the electrophoresis, the gel was
incubated in a renaturing buffer (2.5% Triton
X-100) for 30 min at room temperature and then
incubated for an additional 30 min at room
temperature in developing buffer (5 mM Tris,
20 mM NaCl, 0.5 mM CaCl2, and 0.02% Brij 35, pH
7.6). The gels were then incubated in fresh devel-
oping buffer for 18 h at 37C. The gels were stained
(with 0.5% Coomassie Blue, 40% MeOH, and 10%
acetic acid), destained (40% MeOH, 10% acetic
acid). The intensities of the MMP-2 bands were
quanti®ed by using NIH image (Version 1.65).
RESULTS
Expression of MMP-2 Induced by g-Irradiation
in U2-OS and RKO Cells but Not in MCF-7 and
HepG2 Cells
We have previously shown that p53 positively
regulates the expression of MMP-2 [15]. Since
g-irradiation induces p53 expression [17], we exam-
ined whether g-irradiation could also induce the
expression of MMP-2 in cell lines that express wild-
type p53. Three human cancer cell lines and one
mouse cancer cell line (U2-OS, RKO, MCF-7, and
HepG2) were used in the experiments. The cells
were g-irradiated with 5 Gy (at 1.49 Gy/min
absorbed dose rate). At the time indicated in the
®gures (Figure 1A), the conditioned media were
collected from irradiated and nonirradiated cells.
The MMP-2 activity in the conditioned media were
analyzed by using a gelatin zymography assay. The
results show that there were increased levels of
MMP-2 in irradiated U2-OS and RKO cell lines as
compared with their nonirradiated equivalents
(Figure 1A and B). The quantitative data suggest
that MMP-2 activity began to increase approxi-
mately 4±8 h postirradiation and peaked at 12±24 h
(Figure 2A and B). A 40% increase of MMP-2 was
observed at 24 h postirradiation for U2-OS cells
(Figure 1A) and a 25% increase was observed for
RKO cells (Figure 1B) as compared with their
nonirradiated controls. In contrast to U2-OS and
RKO cells, the MMP-2 activity was not changed after
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Figure 1. Conditioned media from U2-OS and RKO cells show an
increased activity of MMP-2 in the irradiated fractions. U2-OS cells
were cultured in McCoy's 5A medium containing 10% FCS, and the
RKO cells were cultured in RPMI 1640 containing 10% FCS. One day
before irradiation, the cells were seeded into 60-mm tissue culture
plates at 50% con¯uency. The cells were irradiated with an absorbed
dose of 5 Gy. The conditioned media from the irradiated and
nonirradiated U2-OS (A) or irradiated and nonirradiated RKO cells (B)
were collected at various timepoints as indicated. Zymography was
performed on the media to determine the MMP-2 activity present.
The levels of MMP-2 were quantitated by using NIH image (version
1.61).
Figure 2. Normalized graphs of U2-OS and RKO cell lines indi-
cating an increase in MMP-2 and p53 levels after g-irradiation. These
graphs depict the levels of MMP-2 in media over a course of time
compared with the levels of p53 for U2-OS (A) and RKO cells (A) The
MMP-2 and p53 levels were normalized with respect to control time
points taken at the zero-hour time point. The graphs also indicate the
net difference between the irradiated and nonirradiated control cell
extracts and conditioned media that were collected synchronously
during the speci®ed timepoint. The resultant intensity quanti®cation
for the nonirradiated fractions was subtracted from the intensity
quanti®cation fractions, for the irradiated fraction, giving rise to the
net increase of p53 and MMP-2 levels seen on the graphs. The
numbers are the average of three to ®ve sets of data. The calculated
errors for the MMP-2 graphs ranged from 0.06 to  0.43. The
calculated errors for the p53 graphs in ranged  0.07 to  0.32. The
western blots for p21 and bax were also quanti®ed and graphed (B
and C). The calculated errors for the p21 and bax graphs range from
0.11 to  0.85 and 0.08 to  0.26, respectively.
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irradiation in the conditioned media from MCF-7
and HepG2 cells, even though the p53 levels in
these cell lines increased after g-irradiation (data not
shown). The results suggest that MMP-2 expression
can be increased by g-irradiation in certain types of
cell lines.
Radiation-Induced Expression of MMP-2 Correlated
with the Increased Expression of p53
It has been well documented that exposure of cells
to varying doses of g-radiation can increase the
activity of the p53 protein [17]. Further studies have
shown that wild-type p53 plays a role in the
regulation of metastatic factors such as MMP-2
[15]. The U2-OS (human osteosarcoma) and RKO
(human colon carcinoma) tumor cell lines used in
this study both express wild-type p53. The same
dosage (5 Gy) of ionizing radiation that induced
MMP-2 expression was used to treat the cells. The
p53 expression in the g-irradiated and nonirradiated
cells was determined by using western blot analysis.
As shown (Figure 2A and B), this dose of irradiation
also increased p53 expression in those cell lines over
a 24-h time course as compared with nonirradiated
controls. The protein amount loaded on the gel
was monitored and normalized with a b-actin
antibody, a housekeeping protein (Figure 3B). As
shown (Figure 3A and B), the level of p53 pro-
tein increased at 4±8 h postirradiation and peak
levels were reached at 12±24 h after the initial
exposure to ionizing radiation. These results indi-
cate that ionizing radiation can increase the expres-
sion of p53, which correlates with the activation
of MMP2.
In order to con®rm that the expressed p53 is
active, we examined the expression of p21 and bax
upon g-irradiation. Previous data have shown that
activated p53 can induce the increased production
of p21 [18] and bax [19]. The blots were performed
on the p53-expressing U2-OS and RKO cell lines as
well as the p53-negative SAOS and RKO-E6 cell-
lines. Our results indicate that in the p53-positive
Figure 3. Intracellular p53 levels increased in response to ionizing
radiation. The cell lysates were prepared as described in the Materials
and Methods. Equal volumes (8 mL) of lysates were resolved on a
10% SDS-polyacrylamide gel and transferred to nitrocellulose
membranes. The membranes were incubated accordingly with a
®rst antibody, then probed with a horseradish peroxidase±conju-
gated secondary antibody and visualized by using a chemilumines-
cent kit according to the manufacture's procedure (Pierce, Rockford,
IL). (A) p53 expression in irradiated and nonirradiated U2-OS and
RKO cells. A mouse anti-p53 monoclonal antibody (Ab-2, Calbio-
chem, La Jolla CA) was used to detect the level of p53. (B) b-actin
expression in irradiated and nonirradiated U2-OS and RKO cells. The
membrane was incubated with a mouse anti-b-actin polyclonal
antibody (Sigma, St. Louis). (C) bax expression in irradiated and
nonirradiated U2-OS and RKO cells. A rabbit anti-bax antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) was used in this
experiment. (D) p21 expression in irradiated and nonirradiated U2-
OS and RKO cells. The blots were performed by using (a)anti21/WAF
antibody (Santa Cruz Biotechnology).
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cell lines, the cells that were irradiated showed
increased levels of p21 and bax, while the cells that
were not irradiated had constant levels of p21
and bax (Figure 3C and D) with quantitation,
(Fig. 2C and D). The increased expressions of p21
and bax are in accordance with the increase of p53
in the cells (Figure 3A) indicating that the increased
p53 level correlates to the increased activity of p53.
The p53-negative cell lines (SAOS-2 and RKO-E6)
expressed very low levels of p21 or bax, and g-
irradiation has no effect on their expression (data
not shown).
MMP-2 Secretion Dependent on Functional p53
To determine whether wild-type p53 is necessary
for the expression of MMP-2, we examined MMP-2
expression in two p53-negative cell lines. In the ®rst
cell line were SAOS-2 cells, which had the p53 gene
deleted [20]. Previous studies indicate that SAOS-2
cells are devoid of p53 [21]. The second cell line was
the RKO-E6 cells, which are derived from RKO cells
infected with a human papillomavirus E6 gene that
results in the degradation of p53 through an
ubiquitin-mediated pathway [22]. Using these two
cell lines, we analyzed the activity by zymography
and the expression of MMP-2 by western bloting in
both the irradiated and nonirradiated cells. Inter-
estingly, the MMP-2 activities in the conditioned
media from these two cell lines were undetectable
(Figure 4, lanes 2 and 4). The MMP-2 activity in
conditioned media after irradiation was also unde-
tectable (data not shown). However, MMP-2 protein
was expressed in both SAOS-2 and RKO-E6 cells
(Figure 5, lanes 2 and 4). Interestingly, the ratio of
pre-MMP-2 to MMP-2 is much higher in SAOS-2 and
RKO-E6 cells than in U2-OS cells (Figure 5, lanes 2 vs
1) and RKO cells (Figure 5, lane 4 vs 3). The pre±
MMP-2 level was 43% in U2-OS cells, 64% in SAOS-2
cells, 65% in RKO cells, and 79% in RKO-E6 cells.
Our results suggest that p53 may not only be in-
volved in radiation-induced expression of MMP-2
but may also be involved in MMP-2 processing,
activation, and secretion.
DISCUSSION
Tumor metastasis is a complex process and can be
largely divided into three phases: (i) escape of the
tumor cells from the mass of primary tumor and
dissemination of the cells through the lymphatics or
blood vessels, (ii) penetration through vessel walls
and other tissue barriers, and (iii) growth at the new
site [2]. Many genes have been implicated in this
process. Some of the metastasis-associated genes are
regulated either positively or negatively by p53.
Examples include MMP-1, MMP-2, epidermal
growth factor receptor, cathepsin D, basic ®broblast
growth factor, MDR1, thrombospondin-1, and KAI-1
[16,23]. Since radiation has been shown to induce
p53, it has been hypothesized that radiotherapy may
promote tumor metastasis in a subset of human
cancers harboring wild-type p53 [16]. It has also
been found that increased expression of p53 affects
the metastatic potential of certain types of cancers
[24].
Using three human cancer cell lines and one
mouse cancer cell line that harbor wild-type p53, as
well as two p53-negative cell lines, we showed that
the MMP-2 activities in conditioned media har-
vested from U2-OS and RKO cells were induced by g-
irradiation. Interestingly, the MMP-2 activities did
not change in conditioned media harvested from
irradiated HepG2 and MCF-7 cells even though they
showed a signi®cant increase in p53 levels after
radiation treatment (data not shown). Thus, it
appears that MMP-2 activity can only be induced
by g-irradiation in certain types of cells. These
results may explain the previous observations that
radiation therapy can increase hematogenous
metastasis in some tumors but not in others [25].
We have also shown that the radiation-induced
expression of MMP-2 correlated with the expression
level of p53. In U2-OS cells, p53 was induced within
4 h, and MMP-2 activity was increased from 4 to
24 h. Likewise, in RKO cells, p53 was induced at 12 h,
postirradiation, and MMP-2 activity reached its peak
at 24 h. These results further suggest that MMP-2
increase is a consequence of increased levels of wild-
Figure 4. MMP-2 secretion dependent on p53. Zymography of
conditioned media taken from the 24-h time points in four different
cell lines (U2-OS, RKO, SAOS, and RKO-E6) indicated the presence of
MMP-2 activity in the p53-positive cell lines (lanes 1 and 3) but little
or no MMP-2 activity in the p53-negative cell lines (lanes 2 and 4).
Figure 5. Higher pre-MMP-2 level in p53-negative cells. The cell
lysates were prepared as described in the Materials and Methods.
Equal volume (8 mL) of lysates was resolved on a 10% SDS-poly-
acrylamide gel and transferred to a nitrocellulose membrane. The
level of MMP-2 was determined by western blot analysis by using an
MMP-2 Ab-3 antibody (Calbiochem, La Jolla CA). The data indicate
that there was a higher percentage of pre-MMP-2 in p53-negative
cells (lanes 2 and 4) than in p53-positive cells (lanes 1 and 3).
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type p53 induced by exposure to g-radiation. It
is, however, not clear why p53-mediated MMP-2
activation by irradiation is cell-line dependent.
To further con®rm that the increased expression
of MMP-2 is p53 dependent, we examined the MMP-
2 expression after g-irradiation in p53-negative cell
lines. Two p53-negative human cancer cell lines,
SAOS-2 (human osteosarcoma) and RKO-E6 (human
colon cancer), were also used in the study. Indeed,
MMP-2 expression was not induced in these two cell
lines, indicating that MMP-2 induction by g-irradia-
tion is p53-dependent. We also measured the
amounts of p21 and bax in the cell lysates. This
was done because p21 and bax protein levels
correlated with the level of p53 being expressed.
Our data suggest that the levels of p21 and bax
increase as the levels of p53 increase in response to
radiation in U2-OS and RKO cells. The expression
levels of p21 and bax did not increase in SAOS-2 and
RKO-E6 cells (data not shown), which indicates that
the g-irradiation±induced p21 and bax expressions
are p53-dependent. In addition, it was interesting to
®nd that the expressed MMP-2 was not ef®ciently
secreted into the conditioned media by these two
cell lines. Our data suggest that the pre±MMP-2 is
not ef®ciently matured in SAOS-2 and RKO-E6 cells.
These results suggest that p53 may even play a role
in the maturation of MMP-2.
In conclusion, we have shown that wild-type p53
activated by g-irradiation induces an increased level
of MMP-2 expression. The p53 ``status'' of a certain
cancer appears to play a role in the determination of
whether MMP-2 is activated by DNA damage. Thus,
it is possible that a subset of human cancer with
wild-type p53 may undergo metastasis upon radio-
therapy via MMP-2 activation. If this is the case, the
next challenge will be how to determine the
metastatic potential of a patient's tumor when
exposed to radiation. This will require an in-depth
understanding of in vivo regulation of MMP-2 and
other metastasic genes [16] and the tumor context.
Nevertheless, the ®nding reported here serves as the
®rst step in understanding regulation of MMP-2
expression by radiation in the context of p53 status.
MMP-2 status of cancer cells can be potentially used
as a prognostic factor for predicting the outcome of
certain forms of bladder cancer [26]. Thus, a better
understanding of the activation of MMP-2 and p53
by various factors will not only lead to an improved
disease prognosis but also aid in the development
of treatment strategies that are more safe and
effective.
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